B.Braun LogoB.Braun Logo
    • Solutions

      • Aesculap Academy
      • B2B & Industry Partners
      • Customized Kits
      • Discharge Management
      • Medication Management in Oncology
      • Smart Infusion Management
      • Surgical Asset & Supply Management
      • Technical Service
    • Therapies

      • Continence Care and Urology
      • Dental Care
      • Extracorporeal Blood Treatment Therapies
      • Infection Prevention and Control
      • Infusion Therapy
      • Interventional Vascular Therapy
      • Minimally Invasive Surgery
      • Neurosurgery
      • Nutrition Therapy
      • Oncology
      • Orthopaedic Surgery
      • Ostomy Care
      • Pain Therapy
      • Spine Surgery
      • Surgical Instruments & Sterile Container Systems
      • Surgical Power Systems
      • Sutures & Surgical Specialties
      • Wound Management
    Find the product you are looking for. Visit the B. Braun product catalog with our complete portfolio. 

    Product Catalog

    Find the product you are looking for. Visit the B. Braun product catalog with our complete portfolio. 

    B. Braun ensures high security standards throughout the product life cycle by using globally accepted standards.

    Product Security

    B. Braun ensures high security standards throughout the product life cycle by using globally accepted standards.

    • Conditions

      • Chronic Kidney Disease
      • Hydrocephalus
      • Stoma
      • Urinary Retention
    • Services

      • Home Care
      • Hip, Knee  & Spine Surgery
      • Care Centers
      • Infection in hospital
    We coordinate your medical care when discharged from the hospital. For more information, please visit our home care page.

    Home Care

    We coordinate your medical care when discharged from the hospital. For more information, please visit our home care page.

    A planned hospitalization can affect anyone. Did you know that you as patient can do a lot for your own safety and that of other patients? 

    Hygiene & Health

    A planned hospitalization can affect anyone. Did you know that you as patient can do a lot for your own safety and that of other patients? 

    • Our Culture

      • Working at B. Braun
    • Your Opportunities

      • Your Benefits
      • Work & Career
    Discover your career opportunities at B. Braun. Search our global job market for interesting job profiles. 

    Find Your Job

    Discover your career opportunities at B. Braun. Search our global job market for interesting job profiles. 

    • Company

      • Facts & Figures
      • Stories
      • Vision & Values
      • Brand
      • Innovation Hub
    • Responsibility

      • Sustainability
      • Diversity
      • Compliance
      • Access to Health Care
      • Sponsoring & Donations
    • Media

      • Press Releases
      • Images & Videos
      • Publications
    • Contact

      • Locations
      • Vendor Invoices
      • SAP Ariba
      • Contact Form
    Let us drive innovation in medical technology together. Learn more about our innovation hub and present your idea.

    Innovation Hub

    Let us drive innovation in medical technology together. Learn more about our innovation hub and present your idea.

    In dialog with B. Braun. Get in touch with us.

    Contact

    In dialog with B. Braun. Get in touch with us.

  • Products & Solutions
    • Solutions
      • Aesculap Academy
      • B2B & Industry Partners
      • Customized Kits
      • Discharge Management
      • Medication Management in Oncology
      • Smart Infusion Management
      • Surgical Asset & Supply Management
      • Technical Service
    • Therapies
      • Continence Care and Urology
      • Dental Care
      • Extracorporeal Blood Treatment Therapies
      • Infection Prevention and Control
      • Infusion Therapy
      • Interventional Vascular Therapy
      • Minimally Invasive Surgery
      • Neurosurgery
      • Nutrition Therapy
      • Oncology
      • Orthopaedic Surgery
      • Ostomy Care
      • Pain Therapy
      • Spine Surgery
      • Surgical Instruments & Sterile Container Systems
      • Surgical Power Systems
      • Sutures & Surgical Specialties
      • Wound Management
  • Patient Care
    • Conditions
      • Chronic Kidney Disease
      • Hydrocephalus
      • Stoma
      • Urinary Retention
    • Services
      • Home Care
      • Hip, Knee  & Spine Surgery
      • Care Centers
      • Infection in hospital
  • Career
    • Our Culture
      • Working at B. Braun
    • Your Opportunities
      • Your Benefits
      • Work & Career
  • About Us
    • Company
      • Facts & Figures
      • Stories
      • Vision & Values
      • Brand
      • Innovation Hub
    • Responsibility
      • Sustainability
      • Diversity
      • Compliance
      • Access to Health Care
      • Sponsoring & Donations
    • Media
      • Press Releases
      • Images & Videos
      • Publications
    • Contact
      • Locations
      • Vendor Invoices
      • SAP Ariba
      • Contact Form
Global
  • Imprint
  • Terms and conditions
  • Terms of Use
  • Privacy Policy

Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Please contact your country representative for product availability and information. Product images are for reference only.

Copyright © B. Braun SE - version 1.41.1
  • Home
  • Neurosurgery
  • Hydrocephalus & ICP Management
  • Antibiotic Impregnated Catheters
  • MIETHKE XABO®

Product Picture CW Enlargement-MIETHKE XABO®
Product Picture CW Enlargement-MIETHKE XABO®
Product Picture CW Enlargement-MIETHKE XABO®
Product Picture CW Enlargement-MIETHKE XABO®
Product Picture CW Enlargement-MIETHKE XABO®

MIETHKE XABO®
Antibiotic Impregnated Catheters – Xtra Protection Against Infection

One of the most common and potentially serious complications of hydrocephalus treatment is an infection of the shunt [1], affecting 7-15% of hydrocephalus patients [3]. This complication affects pediatric as well as adult patients and impairs their quality of life, cognitive function, and shunt survival [2]. Shunt infections mostly require removal of the shunt, antibiotic treatment and reimplantation [2].

Shunt infections can have severe consequences for the patient: They are associated with a higher risk for further complications, such as seizures, psychomotor retardation, and shunt failure, which increase morbidity and mortality [6–9]. For the neurosurgeon, shunt infections drastically increase the workload and in the worst-case scenario require additional unplanned surgeries.

Use of antibiotic-impregnated catheters can prevent two-thirds of shunt infections [11], thus helping to reduce patient burden and improve patient outcome.

MIETHKE’s new antibiotic-impregnated catheter XABO uses a balanced ratio of clindamycin hydrochloride and rifampicin to effectively fight gram-positive bacteria [12].

XABO antibiotic impregnated catheters offer long-lasting antimicrobial effects, easy handling, convenient storage and perfectly fit all our innovative MIETHKE valves. Patients can benefit from XABO’s optimized release kinetics: the antibiotics are released continuously over at least 38 days after implantation [14], ensuring that XABO’s antimicrobial activity covers the time window when the patient is most susceptible to infection [1, 15-17]. The high potency of the antibiotic impregnation allows for the release of low antibiotic doses, which prevents allergic reactions and minimizes the risk of resistance development.

XABO’s initial antibiotic loading is retained thanks to the gentle sterilization process. In addition, XABO comes wrapped in a specifically designed complete package combination that minimizes degradation products [13], ensuring the antibiotic-impregnated catheter is kept in prime condition for longer. Thanks to the gentle sterilization process and safe packaging it is storable for up to 5 years and withstands temperatures up to 30°C without losing its effectiveness [18].

Indication:

  • Treatment of Hydrocephalus
Read more

One of the most common and potentially serious complications of hydrocephalus treatment is an infection of the shunt [1], affecting 7-15% of hydrocephalus patients [3]. This complication affects pediatric as well as adult patients and impairs their quality of life, cognitive function, and shunt survival [2]. Shunt infections mostly require removal of the shunt, antibiotic treatment and reimplantation [2].

Shunt infections can have severe consequences for the patient: They are associated with a higher risk for further complications, such as seizures, psychomotor retardation, and shunt failure, which increase morbidity and mortality [6–9]. For the neurosurgeon, shunt infections drastically increase the workload and in the worst-case scenario require additional unplanned surgeries.

Use of antibiotic-impregnated catheters can prevent two-thirds of shunt infections [11], thus helping to reduce patient burden and improve patient outcome.

MIETHKE’s new antibiotic-impregnated catheter XABO uses a balanced ratio of clindamycin hydrochloride and rifampicin to effectively fight gram-positive bacteria [12].

XABO antibiotic impregnated catheters offer long-lasting antimicrobial effects, easy handling, convenient storage and perfectly fit all our innovative MIETHKE valves. Patients can benefit from XABO’s optimized release kinetics: the antibiotics are released continuously over at least 38 days after implantation [14], ensuring that XABO’s antimicrobial activity covers the time window when the patient is most susceptible to infection [1, 15-17]. The high potency of the antibiotic impregnation allows for the release of low antibiotic doses, which prevents allergic reactions and minimizes the risk of resistance development.

XABO’s initial antibiotic loading is retained thanks to the gentle sterilization process. In addition, XABO comes wrapped in a specifically designed complete package combination that minimizes degradation products [13], ensuring the antibiotic-impregnated catheter is kept in prime condition for longer. Thanks to the gentle sterilization process and safe packaging it is storable for up to 5 years and withstands temperatures up to 30°C without losing its effectiveness [18].

Indication:

  • Treatment of Hydrocephalus

References

[1] Okamura Y, Maruyama K, Fukuda S, et al. Detailed standardized protocol to prevent cerebrospinal fluid shunt infection. J Neurosurg 2019:1–5.[2] Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006;22(7):692–97.[3] Fernández-Méndez R, Richards HK, Seeley HM, et al. Current epidemiology of cerebrospinal fluid shunt surgery in the UK and Ireland (2004-2013). J Neurol Neurosurg Psychiatry 2019;90(7):747–54.[6] Blount JP, Campbell JA, Haines SJ. Complications in Ventricular Cerebrospinal Fluid Shunting. Neurosurgery Clinics of North America 1993;4(4):633–56.[7] Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004;350(14):1422–29.[8] Walters BC, Hoffman HJ, Hendrick EB, et al. Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 1984;60(5):1014–21.[9] Sciubba DM, Stuart RM, McGirt MJ, et al. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 2005;103(2 Suppl):131–36.[10] Parker SL, McGirt MJ, Murphy JA, et al. Cost savings associated with antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus. World Neurosurg 2015;83(3):382–86.[11] Mallucci CL, Jenkinson MD, Conroy EJ, et al. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation. The Lancet 2019;394(10208):1530–39.[12] MIETHKE report. Data on file.[13] MIETHKE report. Data on file.[14] MIETHKE report. Data on file.[15] Borgbjerg BM, Gjerris F, Albeck MJ, Børgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995;136(1-2):1-7.[16] George R, Leibrock L, Epstein M. Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg. 1979;51(6):804-811.[17] Wells DL, Allen JM. Ventriculoperitoneal shunt infections in adult patients. AACN Adv Crit Care. 2013;24(1):6-14.[18] MIETHKE report. Data on file.